Caricamento...
Ledipasvir and sofosbuvir: Interferon free therapy for hepatitis C virus genotype 1 infection
Hepatitis C virus (HCV) has infected more than 200 million people around the globe. From 2001-2011, interferon plus ribavirin remained the standard of care for patients with HCV infection. The therapy had a limited response with a number of side effects. Recently, results for phase III trials of led...
Salvato in:
| Pubblicato in: | World J Virol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Baishideng Publishing Group Inc
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4308526/ https://ncbi.nlm.nih.gov/pubmed/25674516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5501/wjv.v4.i1.33 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|